Enright Patrick G
CIK 0001253886
Director10% Owner
Filings
27
Latest May 26, 2026
Issuers covered
10
Showing
27 of 27
Page 1
Track record
20 of 22 open-market trades scored (91% price coverage) - 2 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 20 | 80% | +10.5% | +4.5% | +38.1% | -5.9% |
| 90 days | 20 | 70% | +26.5% | +18.1% | +195.4% | -72.0% |
| 180 days | 12 | 67% | +49.8% | +18.8% | +158.2% | -81.0% |
| 365 days | 6 | 50% | +52.3% | -10.1% | +445.9% | -74.0% |
Issuers
Companies where Enright Patrick G has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | 9 | May 26, 2026 |
| JAZZ | Jazz Pharmaceuticals PLC | 4 | Jan 8, 2026 |
| SRRA | Sierra Oncology, Inc. | 3 | Apr 29, 2022 |
| ZBIO | Zenas Biopharma, Inc. | 3 | Oct 14, 2025 |
| BIOA | Bioage Labs, Inc. | 2 | Jun 9, 2025 |
| RPID | Rapid Micro Biosystems, Inc. | 2 | Feb 6, 2026 |
| APTX | Aptinyx Inc. | 1 | May 31, 2022 |
| INZY | Inozyme Pharma, Inc. | 1 | Apr 21, 2022 |
| LXEO | Lexeo Therapeutics, Inc. | 1 | Nov 9, 2023 |
| MANE | Veradermics, Inc | 1 | Feb 5, 2026 |
All filings
27 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|